Core Scientific, Inc. provides net carbon-neutral blockchain infrastructure and digital asset mining solutions in North America. It operates in two segments, Equipment Sales and Hosting. It offers blockchain hosting services with deployment and provide power, racks, proprietary thermodynamic management, redundant connectivity, and 24/7 security, as well as its proprietary software platforms, such as Minder and MinderOS, which provides infrastructure management and custom firmware; and digital asset mining operation focuses on the generation of digital assets by solving complex cryptographic algorithms to validate transactions on specific digital asset network blockchains. The company also offers blockchain infrastructure and third-party hosting services through the sale of consumption-based contracts for its hosting services, as well as equipment sales to customers; and operates data centers in Georgia, Kentucky, North Carolina, North Dakota, and Texas. In addition, it provides hosting services to digital asset mining customers; deployment, monitoring, troubleshooting, optimization, and maintenance services for its customer's digital asset mining equipment; and electrical power and repair, and other infrastructure services to operate, maintain, and mine digital assets. The company is headquartered in Austin, Texas.
IPO Year:
Exchange: NASDAQ
Website: https://www.corescientific.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/23/2025 | $23.50 | Neutral → Buy | Roth Capital |
| 10/22/2025 | $30.00 | Neutral → Buy | B. Riley Securities |
| 9/15/2025 | Buy | Compass Point | |
| 7/22/2025 | $20.00 | Buy | Arete |
| 5/22/2025 | $15.00 | Mkt Outperform | Citizens JMP |
| 1/27/2025 | $22.00 | Outperform | Keefe Bruyette |
| 1/21/2025 | $24.00 | Buy | Craig Hallum |
| 11/15/2024 | $25.50 | Buy | ROTH MKM |
| 10/28/2024 | $19.00 | Buy | Jefferies |
| 9/25/2024 | $16.00 | Outperform | Macquarie |
425 - Core Scientific, Inc./tx (0001839341) (Subject)
8-K - Core Scientific, Inc./tx (0001839341) (Filer)
425 - Core Scientific, Inc./tx (0001839341) (Subject)
DFAN14A - Core Scientific, Inc./tx (0001839341) (Subject)
DFAN14A - Core Scientific, Inc./tx (0001839341) (Subject)
425 - Core Scientific, Inc./tx (0001839341) (Subject)
425 - Core Scientific, Inc./tx (0001839341) (Subject)
425 - Core Scientific, Inc./tx (0001839341) (Subject)
8-K - Core Scientific, Inc./tx (0001839341) (Filer)
DFAN14A - Core Scientific, Inc./tx (0001839341) (Subject)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Roth Capital upgraded Core Scientific from Neutral to Buy and set a new price target of $23.50
B. Riley Securities upgraded Core Scientific from Neutral to Buy and set a new price target of $30.00
Compass Point resumed coverage of Core Scientific with a rating of Buy
Arete initiated coverage of Core Scientific with a rating of Buy and set a new price target of $20.00
Citizens JMP initiated coverage of Core Scientific with a rating of Mkt Outperform and set a new price target of $15.00
Keefe Bruyette initiated coverage of Core Scientific with a rating of Outperform and set a new price target of $22.00
Craig Hallum initiated coverage of Core Scientific with a rating of Buy and set a new price target of $24.00
ROTH MKM initiated coverage of Core Scientific with a rating of Buy and set a new price target of $25.50
Jefferies initiated coverage of Core Scientific with a rating of Buy and set a new price target of $19.00
Macquarie initiated coverage of Core Scientific with a rating of Outperform and set a new price target of $16.00
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
Fastest customizable press release news feed in the world
CoreWeave Disagrees with the Recommendations Against the Transaction Believes the Agreed Upon Transaction Represents Fair Value of the Two Companies Urges Core Scientific Stockholders to Vote FOR the Proposed Transaction on the WHITE Proxy Card on October 30, 2025 CoreWeave Inc. (NASDAQ:CRWV), The Essential Cloud for AI, today commented on the reports published by Institutional Shareholder Services Inc. ("ISS") and Glass, Lewis & Co. ("Glass Lewis") regarding CoreWeave's definitive agreement to acquire Core Scientific, Inc. (NASDAQ:CORZ) in an all-stock transaction. CoreWeave disagrees with the recommendations to vote against this transaction. While neither ISS nor Glass Lewis quest
NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today welcomed the recommendations of both leading independent proxy advisory firms, Institutional Shareholder Services Inc. ("ISS") and Glass Lewis & Co., LLC ("Glass Lewis"), that shareholders of Core Scientific vote "AGAINST" the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) (the "Proposed Merger") ahead of the Company's special meeting of shareholders, which is scheduled to be held on October 30, 2025.
ISS Highlights Numerous Concerns Regarding the Sale Process, Deal Structure and Valuation Agrees with Two Seas That the Board's Flawed Process Did Not Maximize Value for Shareholders NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today applauded leading independent proxy advisory firm Institutional Shareholder Services Inc.'s ("ISS") recommendation that shareholders of Core Scientific vote "AGAINST" the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) on the terms announced on July 7
In the news release, Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave, issued 17-Oct-2025 by Two Seas Capital over PR Newswire, three charts were inadvertently excluded by PR Newswire. The release, with the accompanying charts and the full pdf letter, follows: Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW
Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW YORK, Oct. 17, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today issued a letter to shareholders in connection with its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) on the terms announced on July 7, 2025.
Urges Core Scientific Stockholders to Vote FOR the Proposed Transaction CoreWeave Inc. (NASDAQ:CRWV), The Essential Cloud for AI, today released the following open letter to stockholders of Core Scientific, Inc. (NASDAQ:CORZ). The letter reaffirms CoreWeave's commitment to the proposed acquisition of Core Scientific on the previously agreed terms and corrects inaccurate and misleading statements made by Two Seas Capital ("Two Seas"), an event-driven hedge fund specializing in litigation. Dear Core Scientific Stockholders, CoreWeave entered into a definitive agreement to acquire Core Scientific in an all-stock transaction on July 7, 2025. This transaction represents the most compelling
Highlights Transaction's Flawed Process, Deficient Structure and Inadequate Price Urges Shareholders to Vote AGAINST the Proposed Transaction NEW YORK, Oct. 13, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and the largest active shareholder of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today released an investor presentation, which was filed with the SEC on Friday, October 10, in connection with its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) on the terms announced on July 7, 2025. The full presentation can be found HERE.
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and the largest active shareholder of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ: CORZ), today announced that it has filed its definitive proxy statement with the Securities and Exchange Commission ("SEC") in connection to its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ: CRWV) on the terms announced on July 7, 2025. Two Seas also issued the following letter to fellow Core Scientific sharehold
Issued on behalf of CEA Industries, Inc. VANCOUVER, BC, Sept. 5, 2025 /PRNewswire/ -- USA News Group News Commentary – The cryptocurrency market transformation from speculative trading to strategic corporate adoption reached a decisive turning point in August 2025, as Bitcoin climbed within striking distance of $124,000 all-time highs[1]1 while institutional investors deployed capital at unprecedented scales. Corporate America's embrace of digital assets as treasury reserves has fundamentally shifted market dynamics, with public companies now collectively holding $109.49 billion in Bitcoin[2]2 while Ethereum corporate treasuries exceed $17.6 billion across 19 major firms[3]3. This institutio
USA News Group News Commentary Issued on behalf of CEA Industries, Inc. VANCOUVER, BC, Sept. 5, 2025 /PRNewswire/ -- The cryptocurrency market transformation from speculative trading to strategic corporate adoption reached a decisive turning point in August 2025, as Bitcoin climbed within striking distance of $124,000 all-time highs[1] while institutional investors deployed capital at unprecedented scales. Corporate America's embrace of digital assets as treasury reserves has fundamentally shifted market dynamics, with public companies now collectively holding $109.49 billion in Bitcoin[2] while Ethereum corporate treasuries exceed $17.6 billion across 19 major firms[3]. This institutional v
Live Leadership Updates
In the news release, Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave, issued 17-Oct-2025 by Two Seas Capital over PR Newswire, three charts were inadvertently excluded by PR Newswire. The release, with the accompanying charts and the full pdf letter, follows: Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW
Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW YORK, Oct. 17, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today issued a letter to shareholders in connection with its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) on the terms announced on July 7, 2025.
O2 Investment Partners (www.o2investment.com) is pleased to announce that Xobee Networks (www.xobee.com), a leading managed service provider, has appointed Scott Brueggeman as its Chief Revenue Officer. Mr. Brueggeman brings more than 25 years of leadership experience across technology, infrastructure, and business services companies, with a particular focus on sales, marketing, and go-to-market strategy. Most recently, he served as Chief Marketing Officer at Core Scientific (NASDAQ:CORZ), where he led the company's strategic pivot into AI-driven high-performance computing infrastructure. Prior to that, he held senior executive roles at Logix Fiber Networks, CyrusOne, and CoreLink Data Ce
Jordan Levy Elected Chairman of the Board Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced the appointment of Elizabeth Crain to its Board of Directors, effective immediately. Ms. Crain will also serve as the Chair of the Company's Audit Committee. Ms. Crain brings over 30 years of experience in investment banking, private equity, and executive leadership. She is a Co-Founder and former Chief Operating Officer of Moelis & Company, a leading global independent investment bank. In her role as COO, she oversaw the firm's global strategy, infrastructure, and business operations, playing a key
Industry Veteran Scott Brueggeman Joins Core Scientific as Chief Marketing Officer to Drive Market Expansion and Visibility Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for high-performance computing and digital asset mining, today announced the appointment of Scott Brueggeman as Chief Marketing Officer. With over 20 years of experience in digital infrastructure and technology businesses, Brueggeman will play a pivotal role in strengthening the company's brand presence, driving growth, and expanding market opportunities. Brueggeman brings a proven track record of success in high-growth environments. Most recently, he served
Live finance-specific insights
Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced financial results for the fiscal second quarter of 2025. Fiscal Second Quarter 2025 Financial Results Total revenue was $78.6 million compared to $141.1 million in the second quarter of 2024. Digital asset self-mining revenue was $62.4 million, down from $110.7 million in the prior-year period. The decline was primarily driven by a 62% decrease in bitcoin mined, partially offset by a 50% increase in the average bitcoin price. Digital asset hosted mining revenue was $5.6 million, down from $24.8 million in the same period a year ago.
Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-density colocation services and bitcoin mining, today announced it will release its second quarter fiscal year 2025 financial results after financial markets close on Friday, August 8, 2025. Due to the pending transaction with CoreWeave, Inc., which was previously announced on July 7, 2025, the Company will not be hosting a conference call or webcast to discuss its second quarter fiscal year 2025 results. About Core Scientific, Inc. Core Scientific, Inc. ("Core Scientific" or the "Company") is a leader in digital infrastructure for high-density colocation services and digital asset mining. We operate dedi
Verticalizes Data Center Ownership to Help Future-Proof Revenue Growth and Enhance Core Profitability CoreWeave (NASDAQ:CRWV), the AI Hyperscaler™, and Core Scientific (NASDAQ:CORZ), a leading data center infrastructure provider, today announced that they have signed a definitive agreement under which CoreWeave will acquire Core Scientific in an all-stock transaction. Under the terms of the merger agreement, Core Scientific stockholders will receive 0.1235 newly issued shares of CoreWeave Class A common stock for each share of Core Scientific common stock based on a fixed exchange ratio. Following CoreWeave's successful IPO in March 2025, this acquisition will help CoreWeave verticalize i
First Quarter 2025 Highlights On track to deliver 250MW of billable capacity to CoreWeave by the end of this year and anticipate entering 2026 with annualized colocation revenue of approximately $360 million. First tranche of 8MW of billable capacity at Denton to be delivered to CoreWeave by the end of this month and an additional approximately 40MW by the end of this quarter. Ended the quarter with a strong liquidity position, including $778.6 million in cash and cash equivalents and digital assets, maintaining financial flexibility to execute on strategic organic and inorganic growth opportunities. Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-de
Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for high-performance computing and bitcoin mining, today announced it will issue financial results for the Company's fiscal year 2025 first quarter after financial markets close on Wednesday, May 7, 2025. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the first quarter 2025 will be Adam Sullivan, Chief Executive Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webcast Event Summary Date: May 7
Fourth Quarter 2024 Highlights Incurred net loss of $265.5 million due primarily to a $224.7 million non-cash mark-to-market adjustment to warrants and other contingent value right liabilities required by the significant year-over-year increase in our share price Reported operating loss of $39.8 million, a decrease of $43.7 million over fourth quarter 2023 Generated adjusted EBITDA of $13.3 million, a decrease of $43.4 million over fourth quarter 2023 Secured $625 million through a convertible note offering with favorable 0% interest terms Strengthened the balance sheet, ending the quarter with cash and cash equivalents of $836.2 million as of December 31, 2024 Earned 974
Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for high-performance computing and bitcoin mining, today announced it will issue financial results for the Company's fiscal year 2024 fourth quarter after financial markets close on Wednesday, February 26, 2025. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the fourth quarter 2024 will be Adam Sullivan, Chief Executive Officer, Denise Sterling, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webcast Event Summary
Fiscal Third Quarter 2024 Highlights Incurred net loss of $455.3 million due primarily to a net $408.5 million non-cash mark-to-market adjustment to our warrants and other contingent value right liabilities required as a result of significant quarter-over-quarter increase in the value of our equity Generated operating loss of $41.2 million, an increase of $29.2 million over third quarter 2023 Realized adjusted EBITDA of $10.1 million Customer initiated option exercises resulted in an additional 112 MW during the third quarter and the remaining 120 MW in the fourth quarter for a total of approximately 500 megawatts of critical IT load to host high-performance computing ("HPC"), repre
Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for bitcoin mining and high-performance computing, today announced it will issue financial results for the Company's fiscal year 2024 third quarter after financial markets close on Wednesday, November 6, 2024. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the third quarter 2024 will be Adam Sullivan, Chief Executive Officer, Denise Sterling, Chief Financial Officer, and Steven A. Gitlin, Senior Vice President, Investor Relations. Conference Call and Webcast Event Sum
Fiscal Second Quarter 2024 Highlights Incurred net loss of $804.9 million due primarily to a net $796.0 million non-cash mark-to-market adjustment to our warrants and other contingent value right liabilities required as a result of significant quarter-over-quarter increase in the value of our equity Generated operating income of $6.6 million, a decrease of $2.9 million over second quarter 2023 Produced adjusted EBITDA of $46.0 million Contracted 382 megawatts of infrastructure to host high-performance computing ("HPC"), including latest contract option exercise, for total potential revenue of approximately $6.7 billion over 12 years Achieved mandatory conversion of convertibl
This live feed shows all institutional transactions in real time.
SC 13G - Core Scientific, Inc./tx (0001839341) (Subject)
SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)
SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)
SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)
SC 13G - Core Scientific, Inc./tx (0001839341) (Subject)
SC 13G - Core Scientific, Inc./tx (0001839341) (Subject)
SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)
SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)
SC 13D - Core Scientific, Inc./tx (0001839341) (Subject)
SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)